New Coronavirus Disease 2019 (COVID-19) vaccines are available to prevent the ongoing
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. We compared …

Objective Our objective was to investigate population differences in the metabolic activity of
cytochrome P450 (CYP) 2C9 between genotypically matched Caucasian and Japanese …

Concomitant use of direct oral anticoagulants (DOACs) and medications with inhibition/induction
effect on P‐gp/CYP3A might increase risk of bleeding/treatment failure, respectively. …

Introduction Several fluoroquinolone antibiotics have been associated with cardiac adverse
effects, leading to the withdrawal of some of these agents from the market. Cardiac side …

Objectives To characterize longitudinal symptoms of mild coronavirus disease 2019 (COVID-19)
patients for a period of 6 months, to potentially aid in disease management. Methods …

Sodium–glucose co-transporter-2 inhibitors (SGLT2i) provide outstanding long-term
cardiovascular and renal protection in high-risk patients with type 2 diabetes mellitus. Yet, despite …

Studies reporting an increased risk for cardiac toxicities with macrolide antibiotics have raised
concern regarding their cardiovascular safety. We sought to assess the cardiac safety of …

A major functional component of the blood-brain barrier is P-glycoprotein. In principle, inhibition
of this efflux transporter would permit greater distribution of its substrates into the brain …

Background: Studies indicate that women with atrial fibrillation (AF) are less likely to receive
anticoagulants despite their higher risk of stroke compared with men. Objective: To evaluate …

Background Clinical diagnosis of coronavirus disease 2019 (COVID-19) is essential to the
detection and prevention of COVID-19. Sudden onset of loss of taste and smell is a hallmark …